RxSight Market Cap

RxSight has a market cap or net worth of $2.13 billion as of September 19, 2024. Its market cap has increased by 109.34% in one year.

Market Cap

2.13B

Enterprise Value

1.90B

1-Year Change

109.34%

Ranking

#1894

Market Cap Chart

Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $2.13B, an increase of 400.97%. That is a compound annual growth rate of 67.07%.

Market Cap History

Date	Market Cap	% Change
Sep 18, 2024	2.15B	48.64%
Dec 29, 2023	1.45B	311.70%
Dec 30, 2022	351.20M	14.14%
Dec 31, 2021	307.70M	-27.49%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vera Therapeutics	2.30B
iRhythm Technologies	2.30B
Structure Therapeutics	2.27B
Alignment Healthcare	2.26B
Harmony Biosciences Holdings	2.20B
Keros Therapeutics	2.13B
Soleno Therapeutics	2.12B
Fortrea Holdings	2.11B

Market Cap Rankings